These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1726790)

  • 1. Reciprocal mesenchymal-epithelial interaction affecting prostate tumour growth and hormonal responsiveness.
    Chung LW; Gleave ME; Hsieh JT; Hong SJ; Zhau HE
    Cancer Surv; 1991; 11():91-121. PubMed ID: 1726790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development.
    Cunha GR; Ricke W; Thomson A; Marker PC; Risbridger G; Hayward SW; Wang YZ; Donjacour AA; Kurita T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):221-36. PubMed ID: 15663986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of stromal-epithelial interaction in normal and malignant growth.
    Chung LW
    Cancer Surv; 1995; 23():33-42. PubMed ID: 7621472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors.
    Cunha GR; Alarid ET; Turner T; Donjacour AA; Boutin EL; Foster BA
    J Androl; 1992; 13(6):465-75. PubMed ID: 1293128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
    Gao J; Arnold JT; Isaacs JT
    Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid receptors in prostate cancer tissues and cells: pathophysiology, problems in methodology, clinical value and controversial questions.
    Pavone-Macaluso M; Carruba G; Castagnetta L
    Arch Esp Urol; 1994 Mar; 47(2):189-201. PubMed ID: 8002681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal-epithelial interactions and transforming growth factor-beta 1 expression during normal and abnormal prostatic growth.
    Timme TL; Truong LD; Slawin KM; Kadmon D; Park SH; Thompson TC
    Microsc Res Tech; 1995 Mar; 30(4):333-41. PubMed ID: 7541677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical and biological study of androgen independent prostate cancer (AI PCa).
    Logothetis CJ; Hoosein NM; Hsieh JT
    Semin Oncol; 1994 Oct; 21(5):620-9. PubMed ID: 7524155
    [No Abstract]   [Full Text] [Related]  

  • 9. Keratinocyte growth factor expression in hormone insensitive prostate cancer.
    Leung HY; Mehta P; Gray LB; Collins AT; Robson CN; Neal DE
    Oncogene; 1997 Aug; 15(9):1115-20. PubMed ID: 9285567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of stromal-epithelial interaction in human prostate cancer growth, progression and differentiation.
    Chung LW
    Semin Cancer Biol; 1993 Jun; 4(3):183-92. PubMed ID: 8318694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
    Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
    Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T; Lin FF; Rao P; Lin MF
    Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostatic development, cytodifferentiation and growth: epithelial-mesenchymal interaction and heterogeneity of prostatic cellular activity].
    Sugimura Y; Kawamura J
    Hinyokika Kiyo; 1987 Mar; 33(3):380-90. PubMed ID: 3618405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human prostate cancer progression models and therapeutic intervention.
    Chung LW; Kao C; Sikes RA; Zhau HE
    Hinyokika Kiyo; 1997 Nov; 43(11):815-20. PubMed ID: 9436028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and role of Foxa proteins in prostate cancer.
    Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
    Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
    Hara T; Nakamura K; Araki H; Kusaka M; Yamaoka M
    Cancer Res; 2003 Sep; 63(17):5622-8. PubMed ID: 14500404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human prostate cancer (PC-82) in nude mice: a model to study androgen regulated tumor growth.
    van Steenbrugge GJ; Groen M; Bolt-de Vries J; Romijn JC; Schroeder FH
    Prog Clin Biol Res; 1985; 185A():23-50. PubMed ID: 4034577
    [No Abstract]   [Full Text] [Related]  

  • 19. The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line.
    Karr JF; Kantor JA; Hand PH; Eggensperger DL; Schlom J
    Cancer Res; 1995 Jun; 55(11):2455-62. PubMed ID: 7538903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.